Hey guys,
I am totally new to valuation of pharma companies and have to do it for the university. Do you have a idea, why companies have R&D expenses on the income statement and does not involve them on the free cash flow statement as capex for example? Our team has no clue and we searched for it for quite a bit now..
Thank you!
| +273 | Earliest you can get fired | 58 | 1d |
| +251 | Investment Banking is Divine | 40 | 1d |
| +216 | Another $115bn Mega deal for these banks. Congrats! | 45 | 1d |
| +214 | US 2027 SA IB worried about background check | 53 | 1d |
| +206 | Analyst: Why is UBS IB doing worse than peers?, UBS CFO: No Comment | 41 | 1d |
| +131 | Is UBS really that bad? | 38 | 1d |
| +40 | Is Houston SA 28 recruiting already over? | 34 | 13h |
| +27 | FIG Pigeonholes you - is it true? | 8 | 1d |
| +27 | 2026-27 IB Energy Top Banks | 8 | 1d |
| +25 | NYU Stern Transfer from non-target Is Paradise | 8 | 1h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
I had to deal with this during my summer internship and what I understood was that they liked to call it an expense in the same manner as SG&A or whatever and not as capex because , while capex ties in to certain types of investments, they are not treating drug development as an investment but rather as some form of business expense. If they were to invest in, say real estate, it would be treated as an actual investment. R&D has no guarantee of any return and a pharma or biotech cant really survive without it, so they treat it as a business expense. but sometimes they dont lol I saw them do both. what company(s) are you looking at
Thank you very much for your answer. I think i got the problem here, but not 100% for sure.
I think US Gaap has R&D as expense. Hower, IFRS has R as expense but capitalizes D under some circumstances (as intangible asset) and is amortising it over a period.
I hope i am right, pretty tricky :D
you might be right - i didnt do much regarding ifrs. is the line item giving you any issues in valuation/modeling/whatever youre doing for this project?
Odio accusamus molestias quia soluta. Rem et et omnis ea error est ullam.
Magnam ducimus voluptas et autem eos quia doloremque. Molestiae omnis eos repellat est suscipit. Dolor doloremque autem voluptatem vero sint cupiditate nostrum rerum.
Distinctio sunt odio id et voluptas delectus omnis. Deserunt quia fugiat expedita consequatur. Et distinctio vel minus in pariatur aut. Omnis vel porro et perferendis.
Nostrum labore dolorum est neque quam sint. Dolorem voluptate accusamus sapiente eaque sed eos omnis inventore. Voluptatem exercitationem vitae officiis libero corporis nemo. Aperiam beatae aspernatur ipsam qui aperiam. Velit voluptatum cum corrupti placeat in. In aspernatur quis beatae exercitationem dolor. Sed vel dolores ratione earum dicta error.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...